Kraig Biocraft Laboratories (OTCQB: KBLB) announced that it has produced more than 1.3 metric tons of recombinant spider‑silk cocoons in a single month, a five‑fold jump over the company’s previous record of roughly 0.54 metric tons accumulated over 12 months in 2024. The milestone was achieved using the company’s BAM‑1 Alpha hybrid platform, which has been deployed with more than 700,000 hybrids across its expanded facilities, including a third rearing center acquired in January 2026.
CEO Kim Thompson said the record demonstrates Kraig’s ability to scale production to industrial volumes. “This is a defining moment for our Company and for the future of advanced materials. We told the market we were going to scale fast, and that is exactly what we are doing,” he said. The company’s plan is to target 10 metric tons per month in the coming months, a target that would unlock significant commercial opportunities and move it closer to generating sustainable revenue streams from high‑performance spider‑silk products for performance apparel, technical textiles and other high‑value markets.
While the production achievement is a major operational success, Kraig remains a pre‑revenue company. As of December 31 2025, the company reported significant net losses, a working‑capital deficit, and a going‑concern warning from its auditor. The company has relied on a Standby Equity Purchase Agreement to bolster liquidity, and it has yet to secure commercial contracts that would translate the production milestone into revenue. The company’s financial position tempers the enthusiasm of the production news, and market reaction has been muted as investors weigh the operational breakthrough against the ongoing financial challenges.
The company’s leadership emphasized that the 1.3 metric‑ton output was not a one‑off event. “This wasn’t a one‑off. This was a pressure test of our entire system, our facilities, our hybrids, our team, and every piece delivered,” Thompson said. The BAM‑1 Alpha platform’s success reflects a systematic approach to scaling, with the deployment of more than 700,000 hybrids and the expansion of rearing capacity. The milestone validates the company’s technology and operational model, but the lack of revenue and ongoing losses highlight the gap between production capability and commercial viability.
The achievement positions Kraig as a leader in the emerging spider‑silk market, but the company’s financial fragility and the absence of revenue streams mean that the milestone alone does not alter the long‑term investment thesis. Investors will need to monitor the company’s progress toward commercial contracts and its ability to convert production capacity into profitable revenue streams before reassessing the company’s valuation.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.